The miR-17∼92 cluster, which contains two protective miRNAs, miR-17-5p and miR-20a, has been found to accelerate the disease onset of Eμ-myc-induced B-cell lymphoma, promote lung cancer growth in vitro, activated by c-myc and promote tumor angiogenesis [48]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.